124 related articles for article (PubMed ID: 27451498)
1. [EVALUATION OF THE HUMAN SENSITIVITY TO SMALLPOX VIRUS BY THE PRIMARY CULTURES OF THE MONOCYTE-MACROPHAGES].
Zamedyanskaya AS; Titova KA; Sergeev AA; Kabanov AS; Bulychev LE; Sergeev AA; Galakhova DO; Nesterov AE; Nosareva OV; Shishkina LN; Taranov OS; Omigov VV; Agafonov AP; Sergeev AN
Vopr Virusol; 2016; 61(2):69-73. PubMed ID: 27451498
[TBL] [Abstract][Full Text] [Related]
2. [THE USE OF THE MODEL MOUSE ICR--VARIOLA VIRUS FOR EVALUATION OF ANTIVIRAL DRUG EFFICACY].
Titova KA; Sergeev AA; Kabanov AS; Bulychev LE; Sergeev AA; Galakhova DO; Shishkina LN; Zamedyanskaya AS; Nesterov AE; Glotov AG; Taranov OS; Omigov VV; Agafonov AP; Sergeev AN
Vopr Virusol; 2016; 61(2):79-84. PubMed ID: 27451500
[TBL] [Abstract][Full Text] [Related]
3. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
[TBL] [Abstract][Full Text] [Related]
4. Use of live Variola virus to determine whether CAST/EiJ mice are a suitable surrogate animal model for human smallpox.
Gallardo-Romero NF; Hutson CL; Carroll D; Kondas AV; Salzer JS; Dietz-Ostergaard S; Smith S; Hudson P; Olson V; Damon I
Virus Res; 2020 Jan; 275():197772. PubMed ID: 31593747
[TBL] [Abstract][Full Text] [Related]
5. Dose-related effects of smallpox vaccine.
Frey SE; Newman FK; Cruz J; Shelton WB; Tennant JM; Polach T; Rothman AL; Kennedy JS; Wolff M; Belshe RB; Ennis FA
N Engl J Med; 2002 Apr; 346(17):1275-80. PubMed ID: 11923489
[TBL] [Abstract][Full Text] [Related]
6. [Immune response of the rabbit to smallpox vaccines].
Musetescu M
J Biol Stand; 1974 Jul; 2(3):231-41. PubMed ID: 4372233
[No Abstract] [Full Text] [Related]
7. Biology of Variola Virus.
Gopi P; Krishna G; Veettil MV
Adv Exp Med Biol; 2024; 1451():139-149. PubMed ID: 38801576
[TBL] [Abstract][Full Text] [Related]
8. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
Meseda CA; Weir JP
Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482
[TBL] [Abstract][Full Text] [Related]
9. Clinical responses to undiluted and diluted smallpox vaccine.
Frey SE; Couch RB; Tacket CO; Treanor JJ; Wolff M; Newman FK; Atmar RL; Edelman R; Nolan CM; Belshe RB;
N Engl J Med; 2002 Apr; 346(17):1265-74. PubMed ID: 11923490
[TBL] [Abstract][Full Text] [Related]
10. Should remaining stockpiles of smallpox virus (variola) be destroyed?
Weinstein RS
Emerg Infect Dis; 2011 Apr; 17(4):681-3. PubMed ID: 21470459
[TBL] [Abstract][Full Text] [Related]
11. Using ICR and SCID mice as animal models for smallpox to assess antiviral drug efficacy.
Titova KA; Sergeev AA; Zamedyanskaya AS; Galahova DO; Kabanov AS; Morozova AA; Bulychev LE; Sergeev AA; Glotova TI; Shishkina LN; Taranov OS; Omigov VV; Zavjalov EL; Agafonov AP; Sergeev AN
J Gen Virol; 2015 Sep; 96(9):2832-2843. PubMed ID: 26067292
[TBL] [Abstract][Full Text] [Related]
12. Smallpox in the Post-Eradication Era.
Meyer H; Ehmann R; Smith GL
Viruses; 2020 Jan; 12(2):. PubMed ID: 31991671
[TBL] [Abstract][Full Text] [Related]
13. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
Coulibaly S; Brühl P; Mayrhofer J; Schmid K; Gerencer M; Falkner FG
Virology; 2005 Oct; 341(1):91-101. PubMed ID: 16061267
[TBL] [Abstract][Full Text] [Related]
14. [Experiments on the challenge of the antivaccinial transfer immunity of cell cultures by infection with variola virus. (Evaluation of the antivariola potency of smallpox vaccines)].
Stickl H
Zentralbl Bakteriol Orig; 1968; 208(4):473-85. PubMed ID: 4329545
[No Abstract] [Full Text] [Related]
15. Teaching a new mouse old tricks: Humanized mice as an infection model for Variola virus.
Hutson CL; Kondas AV; Ritter JM; Reed Z; Ostergaard SD; Morgan CN; Gallardo-Romero N; Tansey C; Mauldin MR; Salzer JS; Hughes CM; Goldsmith CS; Carroll D; Olson VA
PLoS Pathog; 2021 Sep; 17(9):e1009633. PubMed ID: 34547055
[TBL] [Abstract][Full Text] [Related]
16. On the origin of smallpox: correlating variola phylogenics with historical smallpox records.
Li Y; Carroll DS; Gardner SN; Walsh MC; Vitalis EA; Damon IK
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15787-92. PubMed ID: 17901212
[TBL] [Abstract][Full Text] [Related]
17. Design and development of oral drugs for the prophylaxis and treatment of smallpox infection.
Painter GR; Hostetler KY
Trends Biotechnol; 2004 Aug; 22(8):423-7. PubMed ID: 15283988
[TBL] [Abstract][Full Text] [Related]
18. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.
Jahrling PB; Hensley LE; Martinez MJ; Leduc JW; Rubins KH; Relman DA; Huggins JW
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15196-200. PubMed ID: 15477589
[TBL] [Abstract][Full Text] [Related]
19. Bioterrorism. Smallpox vaccinations: how much protection remains?
Cohen J
Science; 2001 Nov; 294(5544):985. PubMed ID: 11691969
[No Abstract] [Full Text] [Related]
20. Progression of pathogenic events in cynomolgus macaques infected with variola virus.
Wahl-Jensen V; Cann JA; Rubins KH; Huggins JW; Fisher RW; Johnson AJ; de Kok-Mercado F; Larsen T; Raymond JL; Hensley LE; Jahrling PB
PLoS One; 2011; 6(10):e24832. PubMed ID: 21998632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
